home.social

#swissstockexchange — Public Fediverse posts

Live and recent posts from across the Fediverse tagged #swissstockexchange, aggregated by home.social.

  1. Novartis receives European Commission approval for

    Cosentyx® (secukinumab) becomes first and only IL-17A inhibitor approved in Europe for adults with PMR,1 a common inflammatory…
    #Europe #EU #EuropeanCommission #ChronicIllness #innovation #mediarelease #NovartisPharmaAG #ReimagineMedicine #SwissStockExchange:NOVN.SW
    europesays.com/europe/164077/

Share on Mastodon

Enter the server where you have an account.